Bioeffects of Gas Body Activation in Medical Ultrasound

医学超声中气体激活的生物效应

• 批准号: 7206704
• 负责人: DOUGLAS LAWRENCE MILLER
• 金额: $ 40.92万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-01-01 至 2010-07-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7206704
• 关键词: injury; kidney; tissues; ultrasonography; ultrasound

DESCRIPTION (provided by applicant): Gas body contrast agents bring a demonstrable risk of bioeffects to diagnostic ultrasound for the first time. Our research (and others throughout the world) has established the occurrence of micro-scale damage from contrast aided diagnostic ultrasound. Our laboratory has developed sensitive animal models and specific new tests for microscale bioeffects in heart and kidney. USFDA approved contrast agents and common diagnostic ultrasound scanners are used with carefully calibrated exposure methods to replicate not only the recommended doses and methods of administration of commercially available gas body contrast agents but also the attenuation and extended path lengths encountered in human exposures. It is therefore virtually certain that clinicians worldwide unknowingly cause similar microscale damage while obtaining diagnostic images with these methods. In our preliminary research on rat kidney, contrast gas bodies activated by diagnostic ultrasound ruptured the high pressure glomerular capillaries, and the resulting blood loss into the Bowman's capsule blocked entire nephrons and destroyed the resorptive epithelium of the proximal tubules. Our four specific aims will (1) examine the fundamental biophysics of the bioeffects at the microscopic level, (2) develop new dosimetric parameters and indices to aid clinicians in understanding and avoiding these bioeffects, (3) test common patient situations in which contrast ultrasound bioeffects potentially could result in medically significant injury, and (4) demonstrate ultrasound imaging methods which minimize bioeffects potential. Contrast aided diagnostic ultrasound appears to be a breakthrough for diagnosis but unfortunately progress has been stalled by the bioeffects problem, which is arguably the most pressing research need in medical ultrasound today. In this proposed research, experienced independent researchers will examine comprehensively this problem and resolve it. The establishment of principles and imaging procedures to insure safe use of contrast aided diagnostic ultrasound is urgently needed and achievable. Lay language: Contrast media have been invented to enhance ultrasound images by injecting small gas bubbles into the blood. After approval, research in animals has revealed microscopic damage in heart and kidney caused by the interaction of diagnostic ultrasound with the bubbles. This project will examine bioeffects in cells and tissues and show how to safely use ultrasound contrast agents in diagnostic imaging.

描述(申请人提供)：气体造影剂首次为诊断超声带来了可证明的生物效应风险。我们的研究(和世界各地的其他研究)已经确定了造影剂辅助诊断超声造成的微小损伤的发生。我们的实验室已经开发出敏感的动物模型，并针对心脏和肾脏的微尺度生物效应进行了专门的新测试。USFDA批准的造影剂和普通诊断超声扫描仪与仔细校准的曝光方法一起使用，不仅可以复制商业上可获得的气体造影剂的推荐剂量和给药方法，还可以复制人体暴露中遇到的衰减和延长路径长度。因此，几乎可以肯定的是，世界各地的临床医生在使用这些方法获得诊断图像时，不知不觉中造成了类似的微尺度损害。在我们对大鼠肾脏的初步研究中，由诊断超声激活的造影剂气体破裂了高压肾小球毛细血管，导致血液流入Bowman囊，阻塞了整个肾单位，并破坏了近端小管的吸收上皮。我们的四个具体目标将(1)在微观水平上检查生物效应的基本生物物理学，(2)开发新的剂量学参数和指数来帮助临床医生了解和避免这些生物效应，(3)测试造影剂生物效应可能导致医学上重大损害的常见患者情况，以及(4)展示将生物效应潜力降至最低的超声成像方法。超声造影辅助诊断似乎是诊断的一个突破，但不幸的是，生物效应问题阻碍了进展，生物效应问题可以说是当今医学超声最紧迫的研究需求。在这项拟议的研究中，经验丰富的独立研究人员将全面检查并解决这个问题。建立原则和成像程序以确保造影剂辅助诊断超声的安全使用是迫切需要和可以实现的。外行语言：造影剂已经发明，通过向血液中注入小气泡来增强超声图像。经过批准，在动物身上的研究发现，诊断超声波与气泡相互作用会对心脏和肾脏造成微观损伤。该项目将检查细胞和组织中的生物效应，并展示如何在诊断成像中安全地使用超声造影剂。